- Press Announcements FDA.gov
- UPDATED: Once spurned, Amgen wins the FDA over with its bone-building osteoporosis drug Evenity Endpoints News
- FDA OKs Romosozumab for Postmenopausal Osteoporosis Medscape
- FDA approves new osteoporosis drug for postmenopausal women CNN
- FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture PRNewswire
- View full coverage on Google News
from Business - Latest - Google News http://bit.ly/2KjRlbZ
No comments:
Post a Comment